OS Therapies Updates Quorum Rules for Shareholder Meetings

The latest announcement is out from OS Therapies Incorporated ( (OSTX) ).

On August 15, 2025, OS Therapies Incorporated‘s Board of Directors approved an amendment to the company’s bylaws, changing the quorum requirement for stockholder meetings to one-third of the voting power of outstanding shares. This amendment aims to streamline decision-making processes by allowing a smaller proportion of shareholders to constitute a quorum, potentially impacting the company’s governance and stakeholder engagement.

The most recent analyst rating on (OSTX) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on OS Therapies Incorporated stock, see the OSTX Stock Forecast page.

Spark’s Take on OSTX Stock

According to Spark, TipRanks’ AI Analyst, OSTX is a Underperform.

OS Therapies Incorporated faces significant financial difficulties, marked by increasing net losses, negative cash flows, and reliance on external financing. The technical analysis indicates bearish momentum with the stock trading below its moving averages. Valuation is challenging with no earnings to support a P/E ratio or dividend yield. These factors contribute to a low overall stock score, reflecting the company’s financial instability and negative market sentiment.

To see Spark’s full report on OSTX stock, click here.

More about OS Therapies Incorporated

Average Trading Volume: 504,004

Technical Sentiment Signal: Buy

Current Market Cap: $67.99M

For an in-depth examination of OSTX stock, go to TipRanks’ Overview page.